Manning & Napier Group’s Amgen AMGN Stock Holding History

Manning & Napier Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,000	Closed	-$243K	–	273
2021 Q2	$243K	Hold	1,000	–	–	﹤0.01%	281
2021 Q1	$248K	Hold	1,000	–	–	﹤0.01%	277
2020 Q4	$229K	Hold	1,000	–	–	﹤0.01%	275
2020 Q3	$254K	Hold	1,000	–	–	﹤0.01%	273
2020 Q2	$235K	Sell	1,000 -21,894	-96%	-$5M	﹤0.01%	280
2020 Q1	$4.64M	Sell	22,894 -178,613	-89%	-$39M	0.05%	192
2019 Q4	$48.6M	Buy	201,507 +18,838	+10%	+$4.15M	0.52%	56
2019 Q3	$35.3M	Buy	182,669 +161	+0.1%	+$30.9K	0.4%	66
2019 Q2	$33.6M	Buy	182,508 +12,735	+8%	+$2.28M	0.37%	66
2019 Q1	$32.3M	Buy	169,773 +35,379	+26%	+$6.76M	0.35%	66
2018 Q4	$26.2M	Buy	134,394 +9,461	+8%	+$1.85M	0.32%	66
2018 Q3	$25.9M	Buy	124,933 +7,370	+6%	+$1.45M	0.25%	82
2018 Q2	$21.7M	Sell	117,563 -7,593	-6%	-$1.34M	0.21%	89
2018 Q1	$21.3M	Buy	125,156 +18,371	+17%	+$3.37M	0.21%	88
2017 Q4	$18.6M	Buy	+106,785	New	+$18.9M	0.17%	90

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Manning & Napier Group's AMGN Position: Q3 2021 in Review

Manning & Napier Group sold out of Amgen (AMGN) in Q3 2021, closing a stake of 1,000 shares — an estimated $243K sold.

Manning & Napier Group first reported a position in AMGN in Q4 2017 and held it in 15 quarters. The position peaked at $48.6M in Q4 2019. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

Manning & Napier Group reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
Manning & Napier Group sold 1,000 Amgen shares in Q3 2021, an estimated $243K.
Manning & Napier Group first reported a position in Amgen in Q4 2017 and held it in 15 quarters.
Manning & Napier Group's Amgen position peaked at $48.6M in Q4 2019.
2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Manning & Napier Group's 13F filing for Q3 2021, filed 14 Oct 2021.